Literature DB >> 10389840

No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.

H Sakoda1, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka, T Asano.   

Abstract

Membrane glycoprotein plasma cell 1 (PC-1) has been shown to be increased in type 2 diabetes and involved in insulin resistance through inhibiting the insulin receptor tyrosine kinase, which was demonstrated using cultured breast cancer cells. However, other reports have shown contradictory results in Chinese hamster ovary cells and in vitro kinase assay. Thus, we considered it necessary to investigate the effect of PC-1 using highly insulin-sensitive cells. Here, we used two of the following approaches: 1) investigating PC-1 expression levels in insulin-responsive tissues in rat models of diabetes and 2) overexpressing PC-1 in 3T3-L1 adipocytes. We found that PC-1 was highly expressed in insulin-responsive tissues, such as liver and adipose tissue, in normal rats. However, high-fat feeding or streptozotocin-induced diabetes did not change its expression levels in liver, adipose tissue, and skeletal muscle. Thus, PC-1 expression levels were not associated with high-fat-diet-induced insulin resistance or hyperglycemia. Although PC-1 was increased in adipose tissue in Zucker fatty rats (protein level, by 50%; mRNA level, by 90%), its expression levels in liver and skeletal muscle, tissues that are more responsible for whole body glucose metabolism than adipose tissue, did not significantly differ from those in normal rats. Next, we overexpressed PC-1 in 3T3-L1 adipocytes using an adenovirus transfection system. PC-1 expression was markedly increased to a level 16-fold greater than that in normal human adipose tissue, which is higher than the previously reported levels in diabetic patients. However, insulin-induced tyrosine phosphorylation of the insulin receptor and insulin receptor substrate 1, activation of phosphatidylinositol 3-kinase, and glucose uptake were not affected by PC-1 overexpression. These results strongly suggest that increased PC-1 expression is not causally related to insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389840     DOI: 10.2337/diabetes.48.7.1365

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1.

Authors:  Rik Gijsbers; Hugo Ceulemans; Mathieu Bollen
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

2.  Hepatic ENPP1 expression is induced in diabetic rabbits.

Authors:  Philipp Eller; Kathrin Hochegger; Andreas Wehinger; Ivan Tancevski; Wilfried Schgoer; Andreas Ritsch; Josef R Patsch
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling.

Authors:  Kazuki Kato; Hiroshi Nishimasu; Shinichi Okudaira; Emiko Mihara; Ryuichiro Ishitani; Junichi Takagi; Junken Aoki; Osamu Nureki
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

4.  Increased PC-1 phosphodiesterase activity and inhibition of glucose uptake in adipocytes of type 2 diabetic rats.

Authors:  Karlene Barrett; Donovan McGrowder; Paul Brown; Dalip Ragoobirsingh
Journal:  Mol Cell Biochem       Date:  2006-09-04       Impact factor: 3.396

5.  Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.

Authors:  Gilles Ferry; Edwige Tellier; Anne Try; Sandra Grés; Isabelle Naime; Marie Françoise Simon; Marianne Rodriguez; Jérémie Boucher; Ivan Tack; Stéphane Gesta; Pascale Chomarat; Marc Dieu; Martine Raes; Jean Pierre Galizzi; Philippe Valet; Jean A Boutin; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

6.  Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase.

Authors:  T Ogihara; T Asano; H Katagiri; H Sakoda; M Anai; N Shojima; H Ono; M Fujishiro; A Kushiyama; Y Fukushima; M Kikuchi; N Noguchi; H Aburatani; Y Gotoh; I Komuro; T Fujita
Journal:  Diabetologia       Date:  2004-05-01       Impact factor: 10.122

Review 7.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

8.  ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK.

Authors:  Anita Thyagarajan-Sahu; Brandon Lane; Daniel Sliva
Journal:  BMC Complement Altern Med       Date:  2011-09-19       Impact factor: 3.659

9.  Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus.

Authors:  Chen Zhao; Jinghe Mao; Junmei Ai; Ming Shenwu; Tieliu Shi; Daqing Zhang; Xiaonan Wang; Yunliang Wang; Youping Deng
Journal:  BMC Med Genomics       Date:  2013-01-23       Impact factor: 3.063

10.  Role of ENPP1 on adipocyte maturation.

Authors:  Jian Liang; Mingui Fu; Ester Ciociola; Manisha Chandalia; Nicola Abate
Journal:  PLoS One       Date:  2007-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.